Month: September 2021

Remains on Track to Provide Long Term Strategic Roadmap on Q3 Earnings Call CINCINNATI, Sept. 22, 2021 (GLOBE NEWSWIRE) — Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on providing sustainable and cost-effective drone-integrated electric vehicles to the last-mile delivery sector, today provided an update to its ongoing review of the Company’s business and go-forward operating and commercial plans to transition from an advanced technology start-up to an efficient manufacturing company. The Company has identified a number of enhancements in the production process and design of the C-1000 to address customer feedback, primarily related to vehicle dynamics to increase the vehicles’ payload capacity. As Workhorse has identified these enhancements and continued its review and...

Powder Springs, GA, Sept. 22, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — CBMJ CEO Mark Schaftlein, through his company Capital Consulting Inc., has purchased an additional 31M shares of Restricted Common Stock, $30,000 of Convertible Debt with a current balance of $57,775 in a Private Purchase transaction, and 25% interest in Preferred Stock.  With the addition of the 31M shares, Capital Consulting Inc. now owns a total of 60,913,500 restricted Common Shares, which represents 17% of the total Issued and Outstanding Common shares. This more than doubles the shares controlled by the Company’s CEO.  “Closing this transaction further solidifies continued commitment my fellow Directors and I have to building shareholder value for the long term. Coupled with the recent warrant exercise by Capital Consulting Inc., and an investment...

UBN RELIEF™UBN RELIEF™ is clinically proven to provide some relief from symptoms often related to migraine headaches.LAS VEGAS, Sept. 22, 2021 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based products for heart and brain health, has begun a new double-blind placebo-controlled clinical trial designed to further investigate the ability of UBN RELIEF™ to naturally prevent or alleviate symptoms associated with migraines while improving cognitive function. Neil Wolkodoff, PhD, medical program director of the Colorado Center for Health and Sports Science, will administer the trial, which is anticipated to be completed in November. “We believe our clinical research differentiates our products in the marketplace and assures our customers they are buying a product...

BREXAFEMME® (ibrexafungerp tablets)Product Image #1BREXAFEMME® (ibrexafungerp tablets)Package Image #2BREXAFEMME® (ibrexafungerp tablets)Product LogoSCYNEXIS LogoSCYNEXIS Company LogoFirst and only oral non-azole treatment option approved for vaginal yeast infections is now available in pharmacies including cloud-based pharmacy New treatment is fungicidal against Candida species, disrupting the fungal cell wall and killing the fungi causing the infection, rather than only inhibiting its growthJERSEY CITY, N.J., Sept. 22, 2021 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant fungal infections, today announced the U.S. availability of BREXAFEMME®...

WALTHAM, Mass., Sept. 22, 2021 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will participate in a fireside chat hosted by Jennifer Kim, Vice President, Equity Research, at the 2021 Cantor Virtual Global Healthcare Conference, taking place on Monday, September 27, 2021, at 9:20 a.m. ET. Checkpoint management will also participate in one-on-one meetings during the conference. A live webcast of the fireside chat will be available on the Events page, located within the Investors section of Checkpoint’s website, https://ir.checkpointtx.com/event-calendar/default.aspx, for approximately 30 days following the meeting. About Checkpoint TherapeuticsCheckpoint Therapeutics,...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. MONTREAL, Sept. 22, 2021 (GLOBE NEWSWIRE) — Dominion Water Reserves Corp. (“DWR” or the “Company”) (CSE: DWR), is pleased to announce an investment of $250,000 toward the development of its esker water reserve. As part of its growth strategy and to accelerate its development, DWR will upgrade its installations to facilitate access to bulk transport markets. DWR’s 204 – acre water reserve in the Outaouais region has an authorized annual extraction volume of nearly 1 billion litres, making it the second esker with bottling permit in Quebec with 9.5% of the volume of Quebec’s collection authorizations.    Considering the high quality and available volume of this esker water, DWR is currently in discussion with potential partners, specializing...

FLORHAM PARK, N.J., Sept. 22, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s proprietary Versamune® T-cell activating technology, today announced that its management will present at the Cantor Fitzgerald Virtual Global Healthcare Conference.  The presentation will provide an update on the three ongoing PDS0101 Phase 2 clinical trials. The talk will also provide updates on progression of two other investigational pipeline products PDS0102 (Versamune®-TARP) and PDS0103 (Versamune®-MUC1) into human clinical trials.  The conference is taking place virtually from September 27 – 30, 2021. Details for the presentation are as follows: Cantor Fitzgerald Virtual Global Healthcare Conference:Date: Tuesday, September...